GGrantIndex
← Leaderboards

Arthur M Feldman

University Of Pittsburgh At Pittsburgh

$7,994,094
Attributed
$10,446,590
Total exposure
7
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY200518
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18

Funding mix

By agency

NIH$10,446,590 · 7

By mechanism

R01$3,942,297 · 2
P01$3,902,371 · 3
U01$2,601,922 · 2

Top collaborators

Most similar at University Of Pittsburgh At Pittsburgh

Same institution · by research overlap

Others in their field

Top investigators on “Heart Failure

Research focus

Heart FailureClinical ResearchApoptosisInjuryFunctional DisorderPathway InteractionsCardiacHeartMediatingAffectResponseSecondary ToProteinsPhysiologicalTransgenic MiceLaboratoriesPlayAgonistG-Protein-Coupled ReceptorsAdultIn VivoMouse ModelAdrenergic ReceptorHuman Subject

Grant awards (27)

Involvement of BAG3 in HIV-1 induced cardiomyopathy$716,094
R01 · FY2018 · HL
AVP Type 1A Receptor-Mediated Regulation of Cardiac Function and Stress Response$446,162
P01 · FY2018 · HL · contact PI
Involvement of BAG3 in HIV-1 induced cardiomyopathy$727,859
R01 · FY2017 · HL
AVP Type 1A Receptor-Mediated Regulation of Cardiac Function and Stress Response$446,160
P01 · FY2017 · HL · contact PI
Involvement of BAG3 in HIV-1 induced cardiomyopathy$740,104
R01 · FY2016 · HL
AVP Type 1A Receptor-Mediated Regulation of Cardiac Function and Stress Response$446,160
P01 · FY2016 · HL · contact PI
Involvement of BAG3 in HIV-1 induced cardiomyopathy$736,772
R01 · FY2015 · HL
AVP Type 1A Receptor-Mediated Regulation of Cardiac Function and Stress Response$441,195
P01 · FY2015 · HL · contact PI
Involvement of BAG3 in HIV-1 induced cardiomyopathy$757,915
R01 · FY2014 · HL
AVP Type 1A Receptor-Mediated Regulation of Cardiac Function and Stress Response$445,445
P01 · FY2014 · HL · contact PI
Role of Adenosine Receptors in Cardiac Failure and Protection$390,152
P01 · FY2012 · HL · contact PI
Role of Adenosine Receptors in Cardiac Failure and Protection$289,169
P01 · FY2011 · HL · contact PI
Role of Adenosine Receptors in Cardiac Failure and Protection$498,612
P01 · FY2010 · HL · contact PI
Role of Adenosine Receptors in Cardiac Failure and Protection$499,316
P01 · FY2008 · HL · contact PI
STICH TRIAL - NEUROHORMONAL/ CYTOKINE/ GENETIC CORE LAB$46,792
U01 · FY2007 · HL · contact PI
STICH TRIAL - NEUROHORMONAL/ CYTOKINE/ GENETIC CORE LAB$214,566
U01 · FY2006 · HL · contact PI
STICH TRIAL - NEUROHORMONAL/ CYTOKINE/ GENETIC CORE LAB$157,000
U01 · FY2006 · HL · contact PI
STICH TRIAL - NEUROHORMONAL/ CYTOKINE/ GENETIC CORE LAB$233,899
U01 · FY2005 · HL
STICH TRIAL - NEUROHORMONAL/ CYTOKINE/ GENETIC CORE LAB$25,133
U01 · FY2004 · HL
STICH TRIAL - NEUROHORMONAL/ CYTOKINE/ GENETIC CORE LAB$224,033
U01 · FY2003 · HL
Gene transfer during LVAD support$292,370
U01 · FY2002 · HL
Gene transfer during LVAD support$292,370
U01 · FY2002 · HL
STICH TRIAL - NEUROHORMONAL/ CYTOKINE/ GENETIC CORE LAB$238,649
U01 · FY2002 · HL
Gene transfer during LVAD support$292,370
U01 · FY2001 · HL
Gene transfer during LVAD support$292,370
U01 · FY2001 · HL
Gene transfer during LVAD support$292,370
U01 · FY2000 · HL
CONGESTIVE HEART FAILURE IN TNF ALPHA TRANSGENIC MICE$263,553
R01 · FY2000 · HL